Fig. 2From: Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysisOverall survival (a) and Progression-free survival (b) according to treatment group (Intent to treat analysis: 60 in nCRT group and 60 in nCT group)Back to article page